Begroease-S 50 Tablet ER
Marketer
Leeford Healthcare Ltd
Salt Composition
Mirabegron (50mg) + Solifenacin (5mg)
Overview Begroease-S 50 Tablet ER
Combiflex-50 Extended Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication offers relief from frequent urination, urgency, and incontinence. Always adhere to your physician's prescribed dosage and duration. It can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Common side effects include elevated blood pressure, upper respiratory inflammation (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Prior to commencing treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment should exercise caution, undergoing regular monitoring as directed by their doctor.
Uses of Begroease-S 50 Tablet ER
Symptoms of an overactive bladder
Major Benefits of Begroease-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Begroease-S 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While it can be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Begroease-S 50 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Begroease-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Begroease-S 50 Tablet ER. The tablet should be swallowed whole; do not chew, crush, or divide it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Begroease-S 50 Tablet ER works:
Begroease-S 50 ER tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 agonist, relaxes bladder muscles by stimulating specific receptors. Solifenacin, an antimuscarinic agent, achieves similar bladder muscle relaxation. This dual action reduces the frequency, urgency, and incontinence associated with overactive bladder.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Begroease-S 50 Tablet ER with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Begroease-S 50 Tablet ER in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Begroease-S 50 Tablet ER with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Begroease-S 50 Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Begroease-S 50 Tablet ER in individuals with impaired kidney function is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Begroease-S 50 Tablet ER in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Begroease-S 50 Tablet ER :
NA
Facts to Know About Begroease-S 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urological Care |


